skip to Main Content

Researchers discover novel candidate drug targets for advanced non-alcoholic fatty liver disease

Using the latest technologies-;including both single-nuclear sequencing of mice and human liver tissue and advanced 3D glass imaging of mice to characterize key scar-producing liver cells-;researchers have uncovered novel candidate drug targets for non-alcoholic fatty liver disease (NAFLD).

© 2025 AccentBio. All Rights Reserved.
Site designed by Grid24 a division of Grid24 Ltd.

Back To Top